Clifford Chance
Healthcare & Life Sciences Update: The Netherlands
23 May 2017
The continuously changing Dutch healthcare and life science environment requires companies that are active in the Netherlands to adapt quickly.
This Healthcare & Life Sciences Update sets out some of the latest regulatory developments which may impact your business, such as a new legislative framework on inducement in the medical devices sector, amendment of the rules on clinical trials and the launch of a medicines shortage notification centre.
